SCHEMBL127346

SCHEMBL127346

[CH2]C(O)(CC)CC

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL269968 0.82
SCHEMBL14938555 0.80
SCHEMBL9514161 0.79
SCHEMBL27629711 0.79
SCHEMBL51804 0.78
SCHEMBL1715624 0.78
SCHEMBL5504615 0.77
SCHEMBL270674 0.75
SCHEMBL9864400 0.75
SCHEMBL4923394 0.75

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 110 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117062815-A VMAT2 inhibitors and methods of use 纽罗克里生物科学有限公司 2023-11-14 CN claimed
EP-4168409-A1 VMAT2 INHIBITORS AND METHODS OF USE Neurocrine Biosciences, Inc. (US) 2023-04-26 EP claimed
US-20110056887-A1 REMOVAL OF OXO ANIONS FROM WATER LANXESS DEUTSCHLAND GMBH (DE) 2011-03-10 US claimed
EP-2292561-A2 Removal of oxo anions from silicate-containing water LANXESS Deutschland GmbH (DE) 2011-03-09 EP claimed
US-20090069336-A1 PYRIMIDOTHIOPHENE COMPOUNDS Dymock, Brian William (GB) 2009-03-12 US claimed
EP-1773842-A1 PYRIMIDOTHIOPHENE COMPOUNDS Vernalis (Cambridge) Limited (GB) 2007-04-18 EP claimed
WO-2006008503-A1 PYRIMIDOTHIOPHENE COMPOUNDS VERNALIS (CAMBRIDGE) LTD (GB) 2006-01-26 WO claimed
CN-1438278-A Dye composition containing diamino-pyrazole type oxidation substrate and coupling agent OREAL (FR) 2003-08-27 CN claimed
EP-0705251-A1 IMIDAZOLE DERIVATIVES AS THERAPEUTIC AGENTS Knoll AG (DE) 1996-04-10 EP claimed
US-5047432-A Antidepressants THE BOOTS COMPANY PLC (GB) 1991-09-10 US claimed
CN-1012733-B Process for the preparation of therapeutic agents BOOTS CO PLC (GB) 1991-06-05 CN claimed
EP-0191542-B1 ARYLCYCLOBUTYLALKYL AMINES AND THEIR USE AS ANTIDEPRESSIVE MEDICINES The Boots Company PLC (GB) 1988-06-08 EP claimed
CN-86100954-A The preparation method of therapeutical agent and application 1986-09-03 CN claimed
EP-0191542-A1 Arylcyclobutylalkyl amines and their use as antidepressive medicines The Boots Company PLC (GB) 1986-08-20 EP claimed
EP-4330226-A1 A DIISOCYANATE STABILIZER, USE THEREOF, AND DIISOCYANATE COMPOSITION BASF SE (DE) 2024-03-06 EP disclosed
US-20240010647-A1 SUBSTITUTED PYRIDO[2,1-a]ISOQUINOLINES AS VMAT2 INHIBITORS NEUROCRINE BIOSCIENCES, INC. 2024-01-11 US disclosed
CN-117062815-A VMAT2 inhibitors and methods of use 纽罗克里生物科学有限公司 2023-11-14 CN disclosed
EP-0191542-A1 Arylcyclobutylalkyl amines and their use as antidepressive medicines The Boots Company PLC (GB) 1986-08-20 EP disclosed
US-4243418-A Compositions for fireproofing polyester fiber materials with substituted sulphurylamides CIBA-GEIGY CORPORATION (US) 1981-01-06 US disclosed
US-4128687-A Process for fireproofing polyester fiber materials with substituted sulphurylamides CIBA-GEIGY CORPORATION (US) 1978-12-05 US disclosed